Indeed, Hartmann et al. [6], in a study of 747 IDH-mutant gliomas, found only four patients with two co-occurring IDH1 and IDH2 mutations, while there were no cases of two or more co-occurring IDH1 mutations. The gene discussed is IDH2; the disease is central nervous system cancer.